Skip to Main Content
Table 2—

Prevalence of complications as a percentage of RDNS patients at first and last examinations to the end of 2004

First visitLast visit
Type of diabetes (% type 1) 312 (26.6) — 
Sex (% male) 327 (48.6) — 
DSPN*   
    Σ 5 NC nds (% ≥95th) 327 (34.6) 326 (51.8) 
    NIS (LL) (% ≥2 points) 327 (32.7) 327 (35.2) 
    Σ QST nds (% ≥95th) 77 (27.3) 239 (38.9) 
    NSC number or NSS number (% >1 point) 327 (18.0) 326 (23.0) 
    % ≥DCCT criteria 327 (12.8) 326 (14.1) 
    HP-DB (% ≤5th) 317 (12.6) 287 (13.9) 
Retinopathy (% ≥stage 1) 315 (53.7) 296 (74.0) 
Nephropathy (% ≥stage 1) 82 (26.8) 285 (37.5) 
First visitLast visit
Type of diabetes (% type 1) 312 (26.6) — 
Sex (% male) 327 (48.6) — 
DSPN*   
    Σ 5 NC nds (% ≥95th) 327 (34.6) 326 (51.8) 
    NIS (LL) (% ≥2 points) 327 (32.7) 327 (35.2) 
    Σ QST nds (% ≥95th) 77 (27.3) 239 (38.9) 
    NSC number or NSS number (% >1 point) 327 (18.0) 326 (23.0) 
    % ≥DCCT criteria 327 (12.8) 326 (14.1) 
    HP-DB (% ≤5th) 317 (12.6) 287 (13.9) 
Retinopathy (% ≥stage 1) 315 (53.7) 296 (74.0) 
Nephropathy (% ≥stage 1) 82 (26.8) 285 (37.5) 
*

The different neuropathic end points used are explained under research design and methods and in ref. 28. The staging of retinopathy and nephropathy is given in research design and methods. HP-DB, heart pulse deep breathing; NSS, Neuropathy Symptoms Score.

Close Modal

or Create an Account

Close Modal
Close Modal